sever
acut
respiratori
syndrom
sar
contagi
often
fatal
respiratori
ill
first
report
guangdong
provinc
china
novemb
diseas
quickli
spread
asian
countri
north
america
europ
infect
individu
caus
approxim
recent
sar
began
fade
public
memori
new
coronaviru
call
middl
east
respiratori
syndrom
coronaviru
merscov
emerg
pathogen
human
cov
merscov
sarscov
kill
approxim
infect
patient
saudi
arabia
south
alarm
new
deadli
cov
emerg
time
potenti
becom
pandem
unfortun
neither
protect
vaccin
effect
antivir
agent
prevent
treatment
sar
avail
therefor
continu
develop
therapeut
prophylact
countermeasur
potenti
deadli
cov
warrant
sarscov
crownlik
envelop
viru
contain
positivestrand
rna
whose
genom
sequenc
exhibit
moder
homolog
known
sinc
sarscov
proteas
proteas
papainlik
proteas
plpro
synthes
larg
precursor
protein
cleav
gener
matur
activ
protein
structur
conserv
across
cov
genera
target
protein
effect
antivir
strategi
suppress
viral
genom
replic
cure
cov
continu
interest
natur
productderiv
anticov
candid
report
studi
inhibitori
action
polyphenol
broussonetia
papyrifera
cov
proteas
previous
report
inhibitori
activ
polyphenol
genu
depend
number
prenyl
group
mani
natur
inhibitor
variou
glucosidas
explor
potenti
applic
medicin
carbohydratemedi
diseas
infecti
diseas
endoplasm
reticulum
respons
stepwis
remov
termin
glucos
residu
nglycan
chain
attach
nascent
glycoprotein
reaction
first
step
nlink
glycan
process
essenti
proper
fold
function
mani
viral
envelop
glycoprotein
contain
nlink
glycan
inhibitor
castanospermin
propos
potenti
use
broadspectrum
antivir
agent
base
activ
varieti
envelop
encourag
preliminari
find
focus
attent
investig
antivir
activ
polyphenol
cov
cystein
proteas
character
evalu
antisarsm
activ
follow
b
papyrifera
rootderiv
glucosidas
inhibitor
broussochalcon
broussochalcon
papyriflavonol
kazinol
kazinol
broussoflavan
kazinol
kazinol
j
preliminari
biochem
screen
natur
deriv
compound
compris
authent
inhous
compound
well
isoliquiritigenin
kaempferol
quercetin
perform
assess
potenti
novel
cov
cystein
proteas
inhibitor
vitro
present
result
indic
compound
may
serv
lead
compound
develop
cov
proteas
inhibitor
use
elucid
relationship
vari
polyphenol
root
b
papyrifera
collect
gonyang
sacheon
south
korea
juli
identifi
prof
myong
gi
chung
herbarium
gyeongsang
nation
univers
gnuc
voucher
specimen
khpark
deposit
gnuc
nuclear
magnet
reson
nmr
spectra
analyz
use
bruker
spectromet
bruker
karlsruh
germani
chemic
shift
repres
part
per
million
ppm
thin
layer
chromatographi
tlc
perform
precoat
silicagel
plate
plate
cm
merck
darmstadt
germani
spot
visual
uv
illumin
nm
spray
ethanol
follow
heat
solvent
extract
isol
purchas
sk
chemic
co
seoul
south
korea
redistil
use
deioniz
water
prepar
ultrapur
water
process
milliq
purif
system
millipor
billerica
solvent
nmr
experi
purchas
cambridg
isotop
laboratori
inc
andov
dri
root
b
papyrifera
g
extract
ethanol
l
three
time
room
temperatur
evapor
use
rotari
evapor
temperatur
obtain
total
extract
g
portion
residu
g
fraction
reversedphas
rp
silica
gel
column
cm
ymc
od
aqhg
g
use
puriflash
mediumpressur
liquid
chromatographi
mplc
system
interchim
franc
linear
gradient
mlmin
flow
rate
gener
nine
fraction
bp
fr
bp
fr
exhibit
potent
anticoronavir
activ
among
fraction
select
isol
activ
compound
bp
fr
mg
isol
prepar
highperform
liquid
chromatographi
prephplc
use
plc
person
purif
system
gilson
inc
middleton
wi
water
beh
column
milford
acn
min
min
flow
rate
mlmin
repeat
inject
mgml
meoh
dilut
give
compound
mg
mg
mg
mg
mg
bp
fr
mg
subject
prephplc
use
water
beh
column
acn
min
min
flow
rate
mlmin
repeat
inject
mgml
meoh
dilut
give
compound
mg
mg
mg
mg
mg
isol
compound
identifi
base
spectroscop
data
ethanol
extract
subfract
analyz
ultraperform
liquid
chromatographyphotodiod
arrayquadrupoletim
flightmass
spectrometri
uplcpdaqtofm
chromatograph
separ
perform
mm
water
acquiti
beh
chromatographi
column
mobil
phase
b
water
formic
acid
acetonitril
formic
acid
respect
solvent
gradient
program
follow
min
b
min
b
wash
min
b
recycl
time
min
flow
rate
mlmin
mass
spectromet
oper
posit
ion
mode
use
desolv
ga
desolv
temperatur
set
flow
rate
lh
sourc
temperatur
capillari
cone
voltag
set
v
respect
water
qtof
premiertm
spectromet
oper
v
mode
mass
resolv
power
data
collect
test
sampl
da
scan
time
interscan
delay
analysi
time
use
refer
compound
mz
neg
mode
infus
flow
rate
sequenc
merscov
plpro
genbank
access
number
polyprotein
residu
merscov
genbank
access
number
polyprotein
residu
synthes
bioneer
co
daejeon
south
korea
digest
nheixhoi
insert
vector
novagen
contain
histag
cterminu
figur
construct
plasmid
transform
e
coli
hit
compet
cell
real
biotech
co
taipei
taiwan
streak
lb
agar
plate
contain
kanamycin
largescal
protein
express
cultur
grown
l
lb
medium
absorb
nm
induc
overnight
incub
mm
isopropyl
iptg
centrifug
g
min
cell
pellet
suspend
buffer
mm
sodium
phosphat
mm
nacl
mm
imidazol
triton
ph
lyse
sonic
crude
extract
centrifug
rpm
min
remov
insolubl
pellet
supernat
load
onto
nisepharos
column
equilibr
buffer
column
wash
buffer
protein
sampl
elut
mm
imidazol
elut
buffer
chang
mm
trishcl
buffer
ph
protein
concentr
use
amicon
ultra
filter
molecular
weight
cutoff
merck
millipor
ltd
carrigtwohil
ireland
enzym
concentr
determin
absorb
nm
puriti
molecular
weight
merscov
merscov
plpro
verifi
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
purifi
proteas
approxim
kda
kda
plpro
kinet
paramet
enzymat
activ
analyz
fluoresc
substrat
whose
concentr
rang
k
valu
merscov
merscov
plpro
figur
purifi
protein
store
use
assay
describ
enzym
activ
merscov
measur
cleavag
synthet
peptid
dabcyltsgvlqsglvkedan
site
merscov
polyprotein
use
fluoresc
reson
energi
transfer
fret
method
peptid
synthes
anygen
co
gwangju
south
korea
approxim
puriti
determin
hplc
rp
column
cleavag
activ
enzym
assay
incub
nm
merscov
peptid
substrat
min
total
volum
mm
sodium
phosphat
buffer
contain
mm
nacl
ph
enhanc
fluoresc
due
proteasecatalyz
substrat
cleavag
measur
excit
wavelength
nm
emiss
wavelength
nm
use
fluoresc
plate
reader
bioteck
instrument
inc
winooski
vt
merscov
inhibit
assay
isol
compound
nm
merscov
individu
compound
mix
substrat
fluoresc
intens
monitor
enzym
activ
fit
experiment
data
logist
curv
equat
determin
use
timedr
protocol
initi
veloc
record
rang
concentr
data
analyz
nonlinear
regress
use
sigma
plot
systat
softwar
inc
san
jose
ca
activ
enzym
activ
merscov
plpro
measur
modifi
sarscov
plpro
assay
previous
fluorogen
peptid
argleuargglyglyamc
enzo
life
scienc
farmingdal
ny
nm
purifi
merscov
plpro
mm
sodium
acet
buffer
ph
use
substrat
enzym
respect
inhibit
studi
nm
merscov
plpro
individu
compound
mix
substrat
fluoresc
intens
monitor
excit
emiss
wavelength
nm
respect
spectramax
multimod
micropl
reader
molecular
devic
sunnyval
ca
inhibitori
effect
compound
sarscov
activ
measur
use
fret
assay
fluorogen
peptid
dabcylktsavlqsgfrkmeedan
anygen
co
republ
korea
use
substrat
enzym
activ
determin
measur
increas
fluoresc
intens
continu
monitor
reaction
nm
excit
nm
use
fluoresc
plate
reader
bioteck
instrument
inc
min
reaction
mixtur
contain
sarscov
final
concentr
test
compound
fluorogen
peptid
substrat
mm
bistri
buffer
ph
activ
sarscov
plpro
measur
use
method
previous
describ
inhibit
assay
optim
plate
establish
suitabl
assay
condit
incub
time
fluorogen
peptid
argleuargglyglyamc
enzo
life
scienc
farmingdal
ny
nm
purifi
sarscov
plpro
mm
trishcl
buffer
ph
use
substrat
enzym
respect
inhibit
studi
nm
sarscov
plpro
individu
compound
mix
substrat
fluoresc
intens
monitor
excit
emiss
wavelength
nm
respect
spectramax
multimod
micropl
reader
molecular
devic
studi
kinet
sarscov
plpro
inhibit
compound
variou
concentr
compound
mix
sarscov
plpro
assay
buffer
contain
predetermin
substrat
inhibit
constant
k
calcul
nonlinear
regress
analysi
fit
differ
model
enzym
inhibit
kinet
data
use
sigmaplot
enzym
kinet
modul
systat
softwar
inc
san
jose
ca
inhibit
mechan
compound
determin
compar
statist
result
includ
akaik
inform
criterion
correct
aicc
differ
inhibit
model
select
one
best
fluorogen
substrat
ubamc
enzo
life
scienc
ad
concentr
nm
mm
trishcl
buffer
ph
use
deubiquitin
assay
previous
enzymat
activ
determin
continu
monitor
fluoresc
emiss
excit
wavelength
nm
respect
spectramax
multimod
micropl
reader
molecular
devic
co
sunnyval
ca
releas
amc
measur
manner
describ
sarscov
plpro
inhibit
assay
interferonstimul
gene
amc
boston
biochem
cambridg
perform
plate
mm
trishcl
buffer
ph
contain
nm
sarscov
plpro
variou
concentr
compound
rang
substrat
concentr
nm
releas
amc
monitor
excit
emiss
wavelength
nm
surfac
plasmon
reson
spr
measur
perform
reichert
spr
instrument
depew
ny
kindli
provid
loan
woojung
bsc
inc
suwonsi
korea
enzym
dialyz
phosphatebuff
salin
pb
ph
prior
immobil
surfac
dextranco
chip
cmdh
carboxymethyldextran
hydrogel
chip
activ
inject
edcsulfonh
mixtur
mm
concentr
protein
dilut
use
mm
sodium
acet
buffer
ph
inject
min
activ
site
quench
ethanolamin
buffer
ph
wash
pb
ph
bind
surfac
stabil
blank
inject
pb
use
run
sampl
dilut
buffer
experi
test
inhibitor
first
prepar
mm
stock
solut
dimethyl
sulfoxid
dmso
dilut
pb
immedi
prior
experi
bind
reaction
analyz
autom
run
twofold
dilut
seri
two
zero
concentr
inject
regener
step
perform
use
mm
naoh
data
analyz
softwar
refer
blank
bind
dissoci
curv
fit
global
twostat
bind
kinet
high
potenc
chloroform
extract
indic
presenc
compound
may
therapeut
infecti
therefor
major
compound
bp
fr
expect
exhibit
enzym
inhibitori
activ
uplcpdaqtofm
analys
carri
use
column
linear
gradient
acetonitrilewat
peak
character
use
ms
mz
valu
molecular
ion
mh
compound
respect
supplementari
materi
isol
ten
activ
compound
use
prephplc
octadecylfunction
silica
gel
isol
compound
character
comparison
spectroscop
data
includ
mass
spectral
data
molecular
ion
absorpt
maxima
optic
rotat
publish
compound
identifi
broussochalcon
broussochalcon
papyriflavonol
kazinol
kazinol
broussoflavan
kazinol
kazinol
figur
first
express
cov
cystein
proteas
sarsplpro
mersplpro
e
coli
purifi
protein
homogen
determin
activ
fluorometr
cleavag
assay
valu
isol
compound
measur
abil
inhibit
catalyt
activ
proteas
calcul
fit
data
logic
deriv
equat
also
examin
inhibitori
capac
isol
compound
show
dosedepend
inhibitori
effect
cystein
proteas
result
cov
cystein
proteas
inhibit
assay
summar
tabl
test
polyphenol
show
dosedepend
inhibitori
effect
sarscov
plpro
figur
shown
tabl
compound
potent
sarscov
plpro
compar
cystein
proteas
valu
compound
transcleavag
activ
sarscov
rang
among
isol
polyphenol
group
prenyl
substitut
exhibit
potent
inhibitori
effect
sarscov
effect
quercetin
gener
relationship
deduc
data
exampl
molecul
group
satur
chromenon
dihydroxi
group
ring
c
show
higher
inhibitori
activ
close
prenyl
group
chalcon
biphenyl
propanoid
moder
inhibit
sarscov
activ
furthermor
activ
compound
significantli
affect
subtl
chang
molecular
structur
prenyl
methyl
vide
infra
prenyl
flavon
deriv
exhibit
highest
inhibitori
effect
sarscov
plpro
posit
two
prenyl
group
substanti
effect
sarscov
plpro
inhibit
correspond
compound
sarscov
plpro
inhibitori
potenc
prenyl
flavon
consider
higher
flavon
deriv
includ
keampferol
quercetin
probabl
presenc
prenyl
group
within
resorcinol
group
allow
format
strong
hydrophob
interact
enzym
addit
increas
number
hydroxyl
group
flavon
backbon
result
higher
inhibitori
activ
note
lower
valu
quercetin
compar
kaempferol
among
chalcon
deriv
close
prenyl
ring
chromenon
character
group
ring
b
diminish
proteas
inhibitori
activ
observ
isoliquiritigenin
contrast
number
prenyl
group
degre
satur
effect
prenyl
flavan
shown
tabl
flavan
except
exhibit
moder
inhibitori
activ
valu
rang
addit
compound
contain
methoxi
group
also
present
correspond
biphenyl
propanoid
twofold
effect
unmethyl
investig
proteas
inhibit
mechan
examin
effect
compound
correspond
compound
kinet
substrat
proteolysi
kinet
studi
show
compound
exhibit
noncompetit
inhibit
base
plot
vs
xaxi
intercept
figur
inhibit
sarscov
plpro
activ
decreas
increas
concentr
substrat
inhibitor
studi
exhibit
mode
inhibit
k
valu
compound
calcul
dixon
plot
tabl
surfac
plasmon
reson
use
techniqu
monitor
molecular
reaction
realtim
use
determin
bind
specif
well
rate
associ
dissoci
ligand
target
protein
studi
sarscov
plpro
immobil
sensor
chip
potent
plpro
inhibitor
compound
pass
sensor
surfac
shown
figur
interact
compound
sarscov
plpro
due
specif
bind
event
spr
sensorgram
record
differ
concentr
compound
use
determin
kineticbind
paramet
associ
rate
constant
k
dissoci
rate
constant
k
sarscov
plpro
compound
increas
spr
sensorgram
signific
dosedepend
manner
k
k
dk
interact
compound
sarscov
plpro
indic
classic
interact
k
k
k
although
inhibit
assay
reveal
compound
second
potent
inhibitor
sarscov
plpro
k
higher
compound
recent
year
plpro
focu
numer
studi
develop
chemotherapeut
drug
covinduc
diseas
part
protein
cleav
boundari
recogn
lxgg
consensu
motif
addit
plpro
exhibit
deubiquitin
dub
activ
antagon
induct
interferon
ifn
interferonstimul
gene
one
upregul
gene
upon
type
ifn
stimul
involv
tag
newli
synthes
protein
antivir
respons
ubiquitin
may
import
implic
viral
replic
pathogenesi
sarscov
plpro
cleav
ubiquitin
cellular
conjug
similarli
merscov
plpro
also
shown
possess
dub
activ
thu
effect
anticov
drug
one
inhibit
viral
proteas
activ
well
dub
activ
sinc
inhibit
sarscov
plpro
postul
efficaci
would
higher
dub
activ
compound
strongli
inhibit
cleavag
ubiquitin
valu
respect
complet
substitut
prenyl
group
vs
quercetin
valu
respect
introduct
hydroxyl
group
strongli
affect
activ
quercetin
vs
kaempferol
valu
respect
test
compound
display
moder
inhibit
vitro
cleavag
ubiquitin
tabl
date
function
dub
activ
plpro
vivo
unknown
ident
vivo
cellular
substrat
thu
investig
necessari
determin
specif
inhibit
measur
cleavag
ubiquitinlik
protein
could
reveal
whether
deisgyl
plpro
mechan
sarscov
inactiv
innat
immun
respons
determin
whether
isol
compound
describ
earlier
effect
inhibitor
merscov
cystein
proteas
inhibitori
potenti
assess
use
recombin
pl
proteas
express
laboratori
shown
tabl
none
compound
potent
select
merscov
cystein
proteas
compound
effect
inhibit
merscov
activ
similar
effect
sarscov
also
compar
mode
action
subtl
structur
chang
hand
isol
polyphenol
show
signific
inhibitori
activ
merscov
plpro
valu
rang
potent
merscov
plpro
inhibitor
biphenyl
propanoid
compound
sarscov
recent
emerg
merscov
abl
cross
speci
barrier
spread
rapidli
among
human
studi
assess
inhibitori
activ
polyphenol
deriv
b
papyrifera
cov
cystein
proteas
isol
polyphenol
markedli
inhibit
pl
cov
proteas
valu
compound
though
higher
peptidederiv
inhibitor
still
low
micromolar
rang
particular
isol
compound
exert
signific
sarscov
plpro
inhibitori
activ
noncompetit
inhibit
prenyl
quercetin
deriv
show
potent
plpro
inhibitori
activ
addit
perform
detail
proteininhibitor
sprbind
analys
compound
sarscov
plpro
cellular
deubiquitin
deisgyl
activ
compound
also
discuss
base
enzymat
data
show
signific
activ
compound
cov
proteas
aim
design
effect
cov
inhibitor
futur
studi
